Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.
about
The frequency and biodiversity of poliovirus and non-polio enterovirus strains isolated from healthy children living in a limited area in Romania.Detection of Emerging Vaccine-Related Polioviruses by Deep Sequencing.Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation.Vaccination in elite athletes.Evolution of type 2 vaccine derived poliovirus lineages. Evidence for codon-specific positive selection at three distinct locations on capsid wall.Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern NigeriaA Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine PoliovirusVaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus.Expert review on poliovirus immunity and transmission.Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).Strain-dependent neutralization reveals antigenic variation of human parechovirus 3.Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination.
P2860
Q33790017-56E47E34-7727-47E7-AB6C-D944D15A9100Q33832828-ABBA91E5-C6DE-43CD-BDEC-89B97D2AC032Q33873406-4AEBE554-38B4-40C7-9887-3ECB08B290C4Q34227424-E2B09F25-1BCB-46D5-8A32-222A87FC6B87Q34806015-AA9F271E-D33B-4823-BC78-4733F72E11ECQ36035498-47E86375-21C6-4C96-8F8E-D2BBF34A1CD1Q36433974-B2B49239-EF8C-4DF1-9294-B40C3283D3ECQ36760045-411BA0CA-C971-4244-A223-A276F5C1E6C5Q37002529-8716BCFE-1CEE-4EC6-9B36-0A3A0005FCC9Q37288126-C9F00FAA-432F-435A-9BF7-87FA38674593Q37576028-37006FD4-B6E5-4B9C-A56D-4C298CEFC1F8Q38026922-18297F88-DD0A-4022-8393-C2CC51A670A3Q38087428-133B8B64-3095-4D45-AB5C-4BC4D6A9A97CQ41932454-94C867E3-043B-4D91-AE27-D1A63ABC9133Q42231566-4AB92DA2-6366-48CF-A5FB-BAF2B0F7E6B5
P2860
Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Shedding of vaccine viruses wi ...... ype 1 oral poliovirus vaccine.
@en
Shedding of vaccine viruses wi ...... ype 1 oral poliovirus vaccine.
@nl
type
label
Shedding of vaccine viruses wi ...... ype 1 oral poliovirus vaccine.
@en
Shedding of vaccine viruses wi ...... ype 1 oral poliovirus vaccine.
@nl
prefLabel
Shedding of vaccine viruses wi ...... ype 1 oral poliovirus vaccine.
@en
Shedding of vaccine viruses wi ...... ype 1 oral poliovirus vaccine.
@nl
P2093
P2860
P356
P1433
P1476
Shedding of vaccine viruses wi ...... ype 1 oral poliovirus vaccine.
@en
P2093
Harrie van der Avoort
Jan van de Kassteele
Nasr El-Sayed
Roland W Sutter
Sabine van der Sanden
P2860
P304
P356
10.1128/JVI.02388-08
P407
P577
2009-06-10T00:00:00Z